Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...

Late-Breaking Science Abstract LB 032 - In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting ...

About 795,000 Americans suffer from stroke each year. That’s one about every 40 seconds, according to the Centers for Disease Control and Prevention. Strokes occur when the flow of oxygen and other ...

Understanding seizure causes and their warning signs together with when to seek medical help is crucial because not all ...

Dizziness, numbness, and confusion represent some of the most concerning neurological symptoms that can signal serious underlying medical conditions. While these sensations occasionally result from ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

The Oxford Cognitive Screen is a short, bedside assessment for post-stroke cognitive problems.(Photo credit: Supplied. ) ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and ...